146 related articles for article (PubMed ID: 12729363)
1. Expression of Bcl-2, Bax and p53 proteins in pituitary adenomas: an immunohistochemical study.
Ozer E; Canda MS; Ulukus C; Guray M; Erbayraktar S
Tumori; 2003; 89(1):54-9. PubMed ID: 12729363
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue.
Xie X; Clausen OP; De Angelis P; Boysen M
Cancer; 1999 Sep; 86(6):913-20. PubMed ID: 10491515
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis control and proliferation marker in human normal and neoplastic adrenocortical tissues.
Bernini GP; Moretti A; Viacava P; Bonadio AG; Iacconi P; Miccoli P; Salvetti A
Br J Cancer; 2002 May; 86(10):1561-5. PubMed ID: 12085205
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis and p53 suppressor gene protein expression in human anterior pituitary adenomas.
Green VL; White MC; Hipkin LJ; Jeffreys RV; Foy PM; Atkin SL
Eur J Endocrinol; 1997 Apr; 136(4):382-7. PubMed ID: 9150697
[TBL] [Abstract][Full Text] [Related]
5. [Significance of p53 protein expression and proliferative potential with MIB-1 on tumor recurrence of pituitary adenomas].
Miyagami M; Nakamura S
No To Shinkei; 1998 Jan; 50(1):27-32. PubMed ID: 9493195
[TBL] [Abstract][Full Text] [Related]
6. Correlation of bcl-2 and bax with apoptosis in human pituitary adenomas.
Sambaziotis D; Kapranos N; Kontogeorgos G
Pituitary; 2003; 6(3):127-33. PubMed ID: 14971737
[TBL] [Abstract][Full Text] [Related]
7. Morphogenesis of nonpolypoid colorectal adenomas and early carcinomas assessed by cell proliferation and apoptosis.
Nomura M; Watari J; Yokota K; Saitoh Y; Obara T; Kohgo Y
Virchows Arch; 2000 Jul; 437(1):17-24. PubMed ID: 10963375
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis index and apoptosis-related antigen expression in serrated adenoma of the colorectum: the saw-toothed structure may be related to inhibition of apoptosis.
Tateyama H; Li W; Takahashi E; Miura Y; Sugiura H; Eimoto T
Am J Surg Pathol; 2002 Feb; 26(2):249-56. PubMed ID: 11812948
[TBL] [Abstract][Full Text] [Related]
9. Cell proliferation parameters and apoptosis indices in pituitary macroadenomas.
Ruggeri RM; Costa G; Simone A; Campennì A; Sindoni A; Ieni A; Cavallari V; Trimarchi F; Curtò L
J Endocrinol Invest; 2012 May; 35(5):473-8. PubMed ID: 21897111
[TBL] [Abstract][Full Text] [Related]
10. Expression of p53, p21/waf, bcl-2, bax, Rb and Ki67 proteins in colorectal adenocarcinomas.
Kanavaros P; Stefanaki K; Valassiadou K; Vlachonikolis J; Mavromanolakis M; Vlychou M; Kakolyris S; Gorgoulis V; Tzardi M; Georgoulias V
Med Oncol; 1999 Apr; 16(1):23-30. PubMed ID: 10382939
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemistry with apoptotic-antiapoptotic proteins (p53, p21, bax, bcl-2), c-kit, telomerase, and metallothionein as a diagnostic aid in benign, borderline, and malignant serous and mucinous ovarian tumors.
Ozer H; Yenicesu G; Arici S; Cetin M; Tuncer E; Cetin A
Diagn Pathol; 2012 Sep; 7():124. PubMed ID: 22995373
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of cell survival and cell cycle regulatory proteins in cutaneous squamoproliferative lesions.
Wrone-Smith T; Bergstrom J; Quevedo ME; Reddy V; Gutierrez-Steil C; Nickoloff BJ
J Dermatol Sci; 1999 Jan; 19(1):53-67. PubMed ID: 9890376
[TBL] [Abstract][Full Text] [Related]
13. Mdm2 and the p53 pathway in human pituitary adenomas.
Suliman M; Royds J; Cullen D; Timperley W; Powell T; Battersby R; Jones TH
Clin Endocrinol (Oxf); 2001 Mar; 54(3):317-25. PubMed ID: 11298083
[TBL] [Abstract][Full Text] [Related]
14. [Non-functioning pituitary adenomas: clinical features and immunohistochemistry].
Ferreira JE; de Mello PA; de Magalhães AV; Botelho CH; Naves LA; Nosé V; Schmitt F
Arq Neuropsiquiatr; 2005 Dec; 63(4):1070-8. PubMed ID: 16400431
[TBL] [Abstract][Full Text] [Related]
15. Basal cell adenocarcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2.
Nagao T; Sugano I; Ishida Y; Hasegawa M; Matsuzaki O; Konno A; Kondo Y; Nagao K
Cancer; 1998 Feb; 82(3):439-47. PubMed ID: 9452259
[TBL] [Abstract][Full Text] [Related]
16. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
[TBL] [Abstract][Full Text] [Related]
17. p53, MDM2, bcl-2 staining in follicular neoplasms of the thyroid gland.
Czyz W; Kuzdak K; Pasieka Z; Timler D; Brzeziński J
Folia Histochem Cytobiol; 2001; 39 Suppl 2():167-8. PubMed ID: 11820589
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of p53, p21/WAF1, Bcl-2, Bax, Bak and Ki-67 immunoreactivity in pT1 G3 urothelial bladder carcinomas.
Wolf HK; Stöber C; Hohenfellner R; Leissner J
Tumour Biol; 2001; 22(5):328-36. PubMed ID: 11553864
[TBL] [Abstract][Full Text] [Related]
19. Galectin-3 expression in pituitary adenomas as a marker of aggressive behavior.
Righi A; Morandi L; Leonardi E; Farnedi A; Marucci G; Sisto A; Frank G; Faustini-Fustini M; Zoli M; Mazzatenta D; Agati R; Foschini MP
Hum Pathol; 2013 Nov; 44(11):2400-9. PubMed ID: 24007691
[TBL] [Abstract][Full Text] [Related]
20. Histopathological analysis of apoptosis, and expression of p53, bcl-2, bax, and Ki-67 in laryngeal squamous cell carcinomas and dysplasia.
Izawa H; Yonemitsu N; Shin T; Sugihara H
Auris Nasus Larynx; 1999 Jul; 26(3):317-30. PubMed ID: 10419041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
